Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS
RESEARCH TOOLSreports
Phasebio Pharmaceuticals (PHAS) Financial Statements
0 Followers
Phasebio Pharmaceuticals Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 208.00K | $ 117.00K | $ 158.00K | $ 335.00K | $ 10.34M |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -16.55M | $ -10.99M | $ -42.92M | $ -31.70M | $ -26.82M |
| EBITDA | $ -15.95M | $ -10.39M | $ -42.32M | $ -31.57M | $ -26.24M |
| Net Income Common Stockholders | $ -16.66M | $ -11.14M | $ -43.11M | $ -31.92M | $ -28.68M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 7.80M | $ 18.69M | $ 41.80M | $ 56.36M | $ 64.46M |
| Total Assets | $ 22.17M | $ 38.66M | $ 60.54M | $ 77.72M | $ 100.64M |
| Total Debt | $ 5.37M | $ 6.84M | $ 8.32M | $ 9.78M | $ 11.24M |
| Net Debt | $ -2.43M | $ -11.84M | $ -33.48M | $ -46.57M | $ -53.22M |
| Total Liabilities | $ 139.56M | $ 141.06M | $ 153.57M | $ 128.05M | $ 119.81M |
| Stockholders Equity | $ -117.40M | $ -102.39M | $ -93.03M | $ -50.33M | $ -19.18M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.47M | $ -22.93M | $ -21.65M | $ -6.77M | $ -11.34M |
| Operating Cash Flow | $ -10.41M | $ -22.88M | $ -19.99M | $ -6.13M | $ -11.09M |
| Investing Cash Flow | $ -58.00K | $ -49.00K | $ -1.66M | $ -638.00K | $ -252.00K |
| Financing Cash Flow | $ -415.00K | $ -179.00K | $ 7.09M | $ -1.33M | $ -1.17M |
Phasebio Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.